GTII Stock Overview
Green Thumb Industries Inc. engages in the manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Green Thumb Industries Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$15.45 |
| 52 Week High | CA$16.94 |
| 52 Week Low | CA$8.62 |
| Beta | 1.82 |
| 1 Month Change | 18.85% |
| 3 Month Change | 5.25% |
| 1 Year Change | -0.32% |
| 3 Year Change | -44.64% |
| 5 Year Change | 18.85% |
| Change since IPO | 72.63% |
Recent News & Updates
Recent updates
Is Green Thumb Industries (CSE:GTII) Using Too Much Debt?
Aug 31
Green Thumb Industries (CSE:GTII) Takes On Some Risk With Its Use Of Debt
May 28These 4 Measures Indicate That Green Thumb Industries (CSE:GTII) Is Using Debt Reasonably Well
Feb 27With EPS Growth And More, Green Thumb Industries (CSE:GTII) Makes An Interesting Case
Feb 05Green Thumb Industries (CSE:GTII) Seems To Use Debt Quite Sensibly
Nov 27If EPS Growth Is Important To You, Green Thumb Industries (CSE:GTII) Presents An Opportunity
Oct 17Is Green Thumb Industries (CSE:GTII) Using Too Much Debt?
Aug 09With EPS Growth And More, Green Thumb Industries (CSE:GTII) Makes An Interesting Case
Jul 19Does Green Thumb Industries (CSE:GTII) Have A Healthy Balance Sheet?
Apr 23Earnings Tell The Story For Green Thumb Industries Inc. (CSE:GTII)
Mar 03Green Thumb Industries (CSE:GTII) Has A Pretty Healthy Balance Sheet
Dec 24These 4 Measures Indicate That Green Thumb Industries (CSE:GTII) Is Using Debt Reasonably Well
Sep 18Here's Why Green Thumb Industries Inc.'s (CSE:GTII) CEO May Deserve A Raise
Jun 21We Think That There Are Issues Underlying Green Thumb Industries' (CSE:GTII) Earnings
Mar 25Results: Green Thumb Industries Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Calculating The Intrinsic Value Of Green Thumb Industries Inc. (CSE:GTII)
Mar 08Here's Why Green Thumb Industries (CSE:GTII) Has A Meaningful Debt Burden
Feb 10
Investors Who Bought Green Thumb Industries (CSE:GTII) Shares A Year Ago Are Now Up 176%
Jan 06Green Thumb Industries Inc.'s (CSE:GTII) Has Found A Path To Profitability
Dec 11Shareholder Returns
| GTII | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 9.0% | 9.8% | -1.8% |
| 1Y | -0.3% | -28.5% | 24.6% |
Return vs Industry: GTII exceeded the Canadian Pharmaceuticals industry which returned -28.5% over the past year.
Return vs Market: GTII underperformed the Canadian Market which returned 24.6% over the past year.
Price Volatility
| GTII volatility | |
|---|---|
| GTII Average Weekly Movement | 8.7% |
| Pharmaceuticals Industry Average Movement | 12.8% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 17.9% |
| 10% least volatile stocks in CA Market | 3.5% |
Stable Share Price: GTII is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: GTII's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 4,400 | Ben Kovler | https://www.gtigrows.com |
Green Thumb Industries Inc. engages in the manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores.
Green Thumb Industries Inc. Fundamentals Summary
| GTII fundamental statistics | |
|---|---|
| Market Cap | CA$3.71b |
| Earnings (TTM) | -CA$24.71m |
| Revenue (TTM) | CA$1.41b |
2.6x
P/S Ratio-148.7x
P/E RatioIs GTII overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GTII income statement (TTM) | |
|---|---|
| Revenue | US$1.04b |
| Cost of Revenue | US$527.80m |
| Gross Profit | US$507.79m |
| Other Expenses | US$525.97m |
| Earnings | -US$18.18m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.076 |
| Gross Margin | 49.03% |
| Net Profit Margin | -1.76% |
| Debt/Equity Ratio | 17.5% |
How did GTII perform over the long term?
See historical performance and comparison